Cargando…
A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy
Autores principales: | Cai, Jingjing, Li, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491714/ https://www.ncbi.nlm.nih.gov/pubmed/30904604 http://dx.doi.org/10.1016/j.ebiom.2019.03.052 |
Ejemplares similares
-
New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis
por: Takahara, Shingo, et al.
Publicado: (2019) -
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy
por: Cuevas-Navarro, Antonio, et al.
Publicado: (2023) -
Noonan syndrome caused by RIT1 gene mutation: A case report and literature review
por: Zha, Ping, et al.
Publicado: (2022) -
Noonan syndrome‐associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish
por: Nakagama, Yu, et al.
Publicado: (2019) -
Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1‐associated Noonan syndrome: Expanding the phenotype and review of the literature
por: Aly, Safwat A., et al.
Publicado: (2020)